UK markets closed

Grifols, S.A. (GRF.MC)

MCE - MCE Delayed price. Currency in EUR
Add to watchlist
15.36-0.24 (-1.51%)
At close: 05:35PM CET
Full screen
Previous close15.60
Bid15.38 x 0
Ask15.39 x 0
Day's range15.33 - 15.72
52-week range15.33 - 26.07
Avg. volume1,017,253
Market cap9.091B
Beta (5Y monthly)0.07
PE ratio (TTM)15.86
Earnings dateN/A
Forward dividend & yield0.36 (2.34%)
Ex-dividend date03 Jun 2021
1y target estN/A
  • Reuters

    Spain's Grifols to buy rival Biotest for up to $1.9 billion

    MADRID (Reuters) -Spanish pharmaceuticals company Grifols proposed a 1.6 billion euro ($1.9 billion) takeover of its German rival Biotest on Friday, in a move to consolidate the plasma-based drug industry. Grifols said it had agreed with Tiancheng International Investment to buy the Hong Kong-based company's controlling stake in Biotest for 1.1 billion euros. The Barcelona-based company agreed to buy 89.88% of Biotest's ordinary shares that carry voting rights, but which represent only 44.54% of the company's capital, and a further 0.54% of capital in preferred shares that do not carry voting rights, from Hong Kong-based Tiancheng.

  • Zacks

    Moving Average Crossover Alert: Grifols (GRFS)

    Grifols (GRFS) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.

  • Zacks

    New Strong Sell Stocks for March 8th

    Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today